Droxidopa for the Short‐Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|5|646-654

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.5, 2015-04, pp. : 646-654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – reply

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : e27-e28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comments on: ‘Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – a randomized controlled trial’

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : e4-e4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D deficiency in Parkinson's disease patients with orthostatic hypotension

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 242-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short-Term Lamivudine for the Treatment of Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 367-372

Karger

Access to resources Recommend Favorite

Orthostatic Hypotension in Parkinson Disease: How Much You Fall or How Low You Go?

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 5, 2015-04 ,pp. : 639-645

John Wiley & Sons Inc

Access to resources Recommend Favorite